No Data
No Data
Fuji Pharma: Quarterly Report - 60th Term 2nd Quarter (2024/01/01 - 2024/03/31)
Fuji Pharma: Confirmation
Fuji Pharma Sees 1H Parent Pretax Y2.17B
PARENT New Forecast Prior For Year to Mar 2024 Forecast Revenue Y21.34 bln N/A Pretax Profit Y2.17 bln N/A Net Prof
Fuji Pharma: Summary of Financial Results for the 2nd Quarter Ending 2024/9 [Japanese GAAP] (Consolidated)
Fuji Pharma: Notice regarding differences between the second quarter earnings forecast and actual results and partial revisions to the full-year earnings forecast
Kirin HD, Takeda Pharmaceutical, Sumitomo, SoftBank (9th)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/9 (Thu) <1375>Snow Country Maitake <1720>Tokyu Construction<1738>Nittoh <1764>Kudo Construction<1788>Santo Kogyo <1799>Daiichi Kenset<1869>Meikouken <1870>Yahagi Kenset<1929
No Data